RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
180 Life Sciences Stock

180 Life Sciences ROE 2024

180 Life Sciences ROE

155.74

Ticker

ATNF

ISIN

US68236V1044

WKN

A2QJX5

In 2024, 180 Life Sciences's return on equity (ROE) was 155.74, a -4,662.14% increase from the -3.41 ROE in the previous year.

180 Life Sciences Aktienanalyse

What does 180 Life Sciences do?

180 Life Sciences Corp is a US biotechnology company that focuses on the development of treatments for chronic inflammatory diseases. The company was founded in 2018 and is headquartered in New York City. 180 Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding 180 Life Sciences's Return on Equity (ROE)

180 Life Sciences's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing 180 Life Sciences's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

180 Life Sciences's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in 180 Life Sciences’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about 180 Life Sciences stock

What is the ROE (Return on Equity) of 180 Life Sciences this year?

The ROE of 180 Life Sciences this year is 155.74 undefined.

How has the Return on Equity (ROE) of 180 Life Sciences developed compared to the previous year?

The ROE of 180 Life Sciences has increased by -4,662.14% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of 180 Life Sciences?

A high ROE indicates that 180 Life Sciences generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of 180 Life Sciences?

A low ROE can indicate that 180 Life Sciences is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of 180 Life Sciences affect the company?

A change in ROE (Return on Equity) of 180 Life Sciences can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of 180 Life Sciences?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of 180 Life Sciences?

Some factors that can influence 180 Life Sciences's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does 180 Life Sciences pay?

Over the past 12 months, 180 Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 180 Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of 180 Life Sciences?

The current dividend yield of 180 Life Sciences is .

When does 180 Life Sciences pay dividends?

180 Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 180 Life Sciences?

180 Life Sciences paid dividends every year for the past 0 years.

What is the dividend of 180 Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 180 Life Sciences located?

180 Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von 180 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 180 Life Sciences from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did 180 Life Sciences pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of 180 Life Sciences in the year 2023?

In the year 2023, 180 Life Sciences distributed 0 USD as dividends.

In which currency does 180 Life Sciences pay out the dividend?

The dividends of 180 Life Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 180 Life Sciences

Our stock analysis for 180 Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 180 Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.